Control of regulatory T cell migration, function, and homeostasis

Journal of Immunology

Volumn 195, Issue 6, 2015, Pages 2507-2513

  Campbell, Daniel J ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; MACROPHAGE DERIVED CHEMOKINE; T LYMPHOCYTE RECEPTOR; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

CELL EXPANSION; CELL HOMING; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; LYMPHOID ORGAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; ALLOTRANSPLANTATION; AUTOIMMUNITY; CELL MOTION; CLASSIFICATION; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFLAMMATION; METABOLISM; PHYSIOLOGY;

AUTOIMMUNITY; CELL MOVEMENT; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84941784875     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500801     Document Type: Review

References (89)

1. Ramsdell, F., and S. F. Ziegler. 2014. FOXP3 and scurfy: how it all began. Nat. Rev. Immunol. 14: 343-349.
2. Hsieh, C.-S., Y. Liang, A. J. Tyznik, S. G. Self, D. Liggitt, and A. Y. Rudensky. 2004. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21: 267-277.
3. Jordan, M. S., A. Boesteanu, A. J. Reed, A. L. Petrone, A. E. Holenbeck, M. A. Lerman, A. Naji, and A. J. Caton. 2001. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306.
4. Chen, W., W. Jin, N. Hardegen, K. J. Lei, L. Li, N. Marinos, G. McGrady, and S.M.Wahl. 2003. Conversion of peripheral CD4+CD252naive T cells to CD4+CD25+ regulatory T cells by TGF-b induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
5. Huehn, J., K. Siegmund, J. C. Lehmann, C. Siewert, U. Haubold, M. Feuerer, G. F. Debes, J. Lauber, O. Frey, G. K. Przybylski, et al. 2004. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199: 303-313.
6. Sather, B. D., P.Treuting, N. Perdue,M.Miazgowicz, J. D. Fontenot, A. Y. Rudensky, and D. J. Campbell. 2007. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204: 1335-1347.
7. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336.
8. Smigiel, K. S., E. Richards, S. Srivastava, K. R. Thomas, J. C. Dudda, K. D. Klonowski, and D. J. Campbell. 2014. CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J. Exp. Med. 211: 121-136.
9. Yamaguchi, T., J. B. Wing, and S. Sakaguchi. 2011. Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or noninflammatory conditions. Semin. Immunol. 23: 424-430.
10. Cretney, E., A. Kallies, and S. L. Nutt. 2013. Differentiation and function of Foxp3(+) effector regulatory T cells. Trends Immunol. 34: 74-80.
11. Lee, J. H., S. G. Kang, and C. H. Kim. 2007. FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J. Immunol. 178: 301-311.
12. Tadokoro, C. E., G. Shakhar, S. Shen, Y. Ding, A. C. Lino, A. Maraver, J. J. Lafaille, and M. L. Dustin. 2006. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med. 203: 505-511.
13. Tang, Q., J. Y. Adams, A. J. Tooley, M. Bi, B. T. Fife, P. Serra, P. Santamaria, R. M. Locksley, M. F. Krummel, and J. A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7: 83-92.
14. Mempel, T. R., M. J. Pittet, K. Khazaie, W. Weninger, R. Weissleder, H. von Boehmer, and U. H. von Andrian. 2006. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25: 129-141.
15. Matheu, M. P., S. Othy, M. L. Greenberg, T. X. Dong, M. Schuijs, K. Deswarte, H. Hammad, B. N. Lambrecht, I. Parker, and M. D. Cahalan. 2015. Imaging regulatory T cell dynamics and CTLA4-mediated suppression of T cell priming. Nat. Commun. 6: 6219.
16. Kim, J. M., J. P. Rasmussen, and A. Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8: 191-197.
17. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174: 561-569.
18. Qureshi, O. S., Y. Zheng, K. Nakamura, K. Attridge, C. Manzotti, E. M. Schmidt, J. Baker, L. E. Jeffery, S. Kaur, Z. Briggs, et al. 2011. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332: 600-603.
19. Fallarino, F., U. Grohmann, K. W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, M.-L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4: 1206-1212.
20. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
21. Liu, W., A. L. Putnam, Z. Xu-Yu, G. L. Szot, M. R. Lee, S. Zhu, P. A. Gottlieb, P. Kapranov, T. R. Gingeras, B. Fazekas de St Groth, et al. 2006. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203: 1701-1711.
22. Amado, I. F., J. Berges, R. J. Luther, M.-P. Mailhé, S. Garcia, A. Bandeira, C. Weaver, A. Liston, and A. A. Freitas. 2013. IL-2 coordinates IL-2-producing and regulatory T cell interplay. J. Exp. Med. 210: 2707-2720.
23. Setoguchi, R., S. Hori, T. Takahashi, and S. Sakaguchi. 2005. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201: 723-735.
24. Luther, S. A., H. L. Tang, P. L. Hyman, A. G. Farr, and J. G. Cyster. 2000. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl. Acad. Sci. USA 97: 12694-12699.
25. Barron, L., H. Dooms, K. K. Hoyer, W. Kuswanto, J. Hofmann, W. E. O'Gorman, and A. K. Abbas. 2010. Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J. Immunol. 185: 6426-6430.
26. Long, M., and A. J. Adler. 2006. Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response. J. Immunol. 177: 4257-4261.
27. Sabatos, C. A., J. Doh, S. Chakravarti, R. S. Friedman, P. G. Pandurangi, A. J. Tooley, and M. F. Krummel. 2008. A synaptic basis for paracrine interleukin-2 signaling during homotypic T cell interaction. Immunity 29: 238-248.
28. Levine, A. G., A. Arvey, W. Jin, and A. Y. Rudensky. 2014. Continuous requirement for the TCR in regulatory T cell function. Nat. Immunol. 15: 1070-1078.
29. Rosenblum, M. D., I. K. Gratz, J. S. Paw, K. Lee, A. Marshak-Rothstein, and A. K. Abbas. 2011. Response to self antigen imprints regulatory memory in tissues. Nature 480: 538-542.
30. Rowe, J. H., J. M. Ertelt, L. Xin, and S. S. Way. 2012. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490: 102-106.
31. Samstein, R. M., S. Z. Josefowicz, A. Arvey, P. M. Treuting, and A. Y. Rudensky. 2012. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150: 29-38.
32. Chow, Z., A. Banerjee, and M. J. Hickey. 2015. Controlling the fire-tissue-specific mechanisms of effector regulatory T-cell homing. Immunol. Cell Biol. 93: 355-363.
33. Gratz, I. K., and D. J. Campbell. 2014. Organ-specific and memory treg cells: specificity, development, function, and maintenance. Front. Immunol. 5: 333.
34. Dudda, J. C., N. Perdue, E. Bachtanian, and D. J. Campbell. 2008. Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 205: 1559-1565.
35. Siegmund, K., M. Feuerer, C. Siewert, S. Ghani, U. Haubold, A. Dankof, V. Krenn, M. P. Schön, A. Scheffold, J. B. Lowe, et al. 2005. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106: 3097-3104.
36. Denning, T. L., G. Kim, and M. Kronenberg. 2005. Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J. Immunol. 174: 7487-7491.
37. Kim, S. V., W. V. Xiang, C. Kwak, Y. Yang, X. W. Lin, M. Ota, U. Sarpel, D. B. Rifkin, R. Xu, and D. R. Littman. 2013. GPR15-mediated homing controls immune homeostasis in the large intestine mucosa. Science 340: 1456-1459.
38. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Cárcamo, J. Hall, C.-M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic aciddependent mechanism. J. Exp. Med. 204: 1757-1764.
39. Jaensson, E., H. Uronen-Hansson, O. Pabst, B. Eksteen, J. Tian, J. L. Coombes, P.-L. Berg, T. Davidsson, F. Powrie, B. Johansson-Lindbom, and W.W. Agace. 2008. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J. Exp. Med. 205: 2139-2149.
40. Iwata, M., A. Hirakiyama, Y. Eshima, H. Kagechika, C. Kato, and S.-Y. Song. 2004. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21: 527-538.
41. Arpaia, N., C. Campbell, X. Fan, S. Dikiy, J. van der Veeken, P. deRoos, H. Liu, J. R. Cross, K. Pfeffer, P. J. Coffer, and A. Y. Rudensky. 2013. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504: 451-455.
42. Smith, P. M., M. R. Howitt, N. Panikov, M. Michaud, C. A. Gallini, M. Bohlooly-Y, J. N. Glickman, and W. S. Garrett. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341: 569-573.
43. Furusawa, Y., Y. Obata, S. Fukuda, T. A. Endo, G. Nakato, D. Takahashi, Y. Nakanishi, C. Uetake, K. Kato, T. Kato, et al. 2013. Commensal microbederived butyrate induces the differentiation of colonic regulatory T cells. Nature 504: 446-450.
44. Hall, J. A., N. Bouladoux, C. M. Sun, E. A. Wohlfert, R. B. Blank, Q. Zhu, M. E. Grigg, J. A. Berzofsky, and Y. Belkaid. 2008. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 29: 637-649.
45. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+ CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
46. Naik, S., N. Bouladoux, C. Wilhelm, M. J. Molloy, R. Salcedo, W. Kastenmuller, C. Deming, M. Quinones, L. Koo, S. Conlan, et al. 2012. Compartmentalized control of skin immunity by resident commensals. Science 337: 1115-1119.
47. Sanchez Rodriguez, R., M. L. Pauli, I. M. Neuhaus, S. S. Yu, S. T. Arron, H. W. Harris, S. H.-Y. Yang, B. A. Anthony, F. M. Sverdrup, E. Krow-Lucal, et al. 2014. Memory regulatory T cells reside in human skin. J. Clin. Invest. 124: 1027-1036.
48. Mora, J. R., G. Cheng, D. Picarella, M. Briskin, N. Buchanan, and U. H. von Andrian. 2005. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J. Exp. Med. 201: 303-316.
49. Campbell, D. J., and M. A. Koch. 2011. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 11: 119-130.
50. Yamazaki, T., X. O. Yang, Y. Chung, A. Fukunaga, R. Nurieva, B. Pappu, N. Martin-Orozco, H. S. Kang, L. Ma, A. D. Panopoulos, et al. 2008. CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 181: 8391-8401.
51. Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, et al. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204: 2803-2812.
52. Zhang, N., B. Schröppel, G. Lal, C. Jakubzick, X. Mao, D. Chen, N. Yin, R. Jessberger, J. C. Ochando, Y. Ding, and J. S. Bromberg. 2009. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 30: 458-469.
53. Yurchenko, E., M. Tritt, V. Hay, E. M. Shevach, Y. Belkaid, and C. A. Piccirillo. 2006. CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J. Exp. Med. 203: 2451-2460.
54. Kang, S. G., R. J. Piniecki, H. Hogenesch, H. W. Lim, E. Wiebke, S. E. Braun, S. Matsumoto, and C. H. Kim. 2007. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine. Gastroenterology 132: 966-981.
55. Glatigny, S., R. Duhen, C. Arbelaez, S. Kumari, and E. Bettelli. 2015. Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4. Sci. Rep. 5: 7834.
56. Cipolletta, D., M. Feuerer, A. Li, N. Kamei, J. Lee, S. E. Shoelson, C. Benoist, and D. Mathis. 2012. PPAR-g is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486: 549-553.
57. Burzyn, D., W. Kuswanto, D. Kolodin, J. L. Shadrach, M. Cerletti, Y. Jang, E. Sefik, T. G. Tan, A. J. Wagers, C. Benoist, and D. Mathis. 2013. A special population of regulatory T cells potentiates muscle repair. Cell 155: 1282-1295.
58. Vasanthakumar, A., K. Moro, A. Xin, Y. Liao, R. Gloury, S. Kawamoto, S. Fagarasan, L. A. Mielke, S. Afshar-Sterle, S. L. Masters, et al. 2015. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 16: 276-285.
59. Burmeister, Y., T. Lischke, A. C. Dahler, H. W. Mages, K. P. Lam, A. J. Coyle, R. A. Kroczek, and A. Hutloff. 2008. ICOS controls the pool size of effectormemory and regulatory T cells. J. Immunol. 180: 774-782.
60. Tai, X., B. Erman, A. Alag, J. Mu, M. Kimura, G. Katz, T. Guinter, T. McCaughtry, R. Etzensperger, L. Feigenbaum, et al. 2013. Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity 38: 1116-1128.
61. Cretney, E., A. Xin, W. Shi, M. Minnich, F. Masson, M. Miasari, G. T. Belz, G. K. Smyth, M. Busslinger, S. L. Nutt, and A. Kallies. 2011. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12: 304-311.
62. Matta, B. M., J. M. Lott, L. R. Mathews, Q. Liu, B. R. Rosborough, B. R. Blazar, and H. R. Turnquist. 2014. IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. J. Immunol. 193: 4010-4020.
63. Schiering, C., T. Krausgruber, A. Chomka, A. Fröhlich, K. Adelmann, E. A. Wohlfert, J. Pott, T. Griseri, J. Bollrath, A. N. Hegazy, et al. 2014. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513: 564-568.
64. Gratz, I. K., H.-A. Truong, S. H.-Y. Yang, M. M. Maurano, K. Lee, A. K. Abbas, and M. D. Rosenblum. 2013. Cutting edge: memory regulatory T cells require IL-7 and not IL-2 for their maintenance in peripheral tissues. J. Immunol. 190: 4483-4487.
65. Makita, S., T. Kanai, S. Oshima, K. Uraushihara, T. Totsuka, T. Sawada, T. Nakamura, K. Koganei, T. Fukushima, and M. Watanabe. 2004. CD4 +CD25bright T cells in human intestinal lamina propria as regulatory cells. J. Immunol. 173: 3119-3130.
66. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Bäckström, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431.
67. Tang, Q., J. Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, and J. A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
68. Bayer, A. L., A. Pugliese, and T. R. Malek. 2013. The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation. Immunol. Res. 57: 197-209.
69. Grinberg-Bleyer, Y., A. Baeyens, S. You, R. Elhage, G. Fourcade, S. Gregoire, N. Cagnard, W. Carpentier, Q. Tang, J. Bluestone, et al. 2010. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J. Exp. Med. 207: 1871-1878.
70. Wesley, J. D., B. D. Sather, N. R. Perdue, S. F. Ziegler, and D. J. Campbell. 2010. Cellular requirements for diabetes induction in DO11.10xRIPmOVA mice. J. Immunol. 185: 4760-4768.
71. Long, S. A., J. H. Buckner, and C. J. Greenbaum. 2013. IL-2 therapy in type 1 diabetes: "Trials" and tribulations. Clin. Immunol. 149: 324-331.
72. Tang, Q., and J. A. Bluestone. 2013. Regulatory T-cell therapy in transplantation: moving to the clinic. Cold Spring Harb. Perspect. Med. 3(11).
73. Collison, L. W., V. Chaturvedi, A. L. Henderson, P. R. Giacomin, C. Guy, J. Bankoti, D. Finkelstein, K. Forbes, C. J. Workman, S. A. Brown, et al. 2010. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11: 1093-1101.
74. Andersson, J., D. Q. Tran, M. Pesu, T. S. Davidson, H. Ramsey, J. J. O'Shea, and E. M. Shevach. 2008. CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J. Exp. Med. 205: 1975-1981.
75. Mora, J. R., M. R. Bono, N. Manjunath, W. Weninger, L. L. Cavanagh, M. Rosemblatt, and U. H. Von Andrian. 2003. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424: 88-93.
76. Koch, M. A., K. R. Thomas, N. R. Perdue, K. S. Smigiel, S. Srivastava, and D. J. Campbell. 2012. T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor b2. Immunity 37: 501-510.
77. Hall, A. O., D. P. Beiting, C. Tato, B. John, G. Oldenhove, C. G. Lombana, G. H. Pritchard, J. S. Silver, N. Bouladoux, J. S. Stumhofer, et al. 2012. The cytokines interleukin 27 and interferon-g promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 37: 511-523.
78. Srivastava, S., M. A. Koch, M. Pepper, and D. J. Campbell. 2014. Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection. J. Exp. Med. 211: 961-974.
79. Srivastava, S., L. K. Koch, and D. J. Campbell. 2014. IFNaR signaling in effector but not regulatory T cells is required for immune dysregulation during type I IFNdependent inflammatory disease. J. Immunol. 193: 2733-2742.
80. Schneider, A., S. A. Long, K. Cerosaletti, C. T. Ni, P. Samuels, M. Kita, and J. H. Buckner. 2013. In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling. Sci. Transl. Med. 5: 170ra15.
81. Bailey-Bucktrout, S. L., M. Martinez-Llordella, X. Zhou, B. Anthony, W. Rosenthal, H. Luche, H. J. Fehling, and J. A. Bluestone. 2013. Self-antigendriven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 39: 949-962.
82. Long, S. A., and J. H. Buckner. 2011. CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game. J. Immunol. 187: 2061-2066.
83. Nishikawa, H., and S. Sakaguchi. 2014. Regulatory T cells in cancer immunotherapy. Curr. Opin. Immunol. 27: 1-7.
84. Phan, G. Q., J. C. Yang, R. M. Sherry, P. Hwu, S. L. Topalian, D. J. Schwartzentruber, N. P. Restifo, L. R. Haworth, C. A. Seipp, L. J. Freezer, et al. 2003. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA 100: 8372-8377.
85. Curiel, T. J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J. R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10: 942-949.
86. Faget, J., C. Biota, T. Bachelot, M. Gobert, I. Treilleux, N. Goutagny, I. Durand, S. Léon-Goddard, J. Y. Blay, C. Caux, and C. Ménétrier-Caux. 2011. Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells. Cancer Res. 71: 6143-6152.
87. Sugiyama, D., H. Nishikawa, Y. Maeda, M. Nishioka, A. Tanemura, I. Katayama, S. Ezoe, Y. Kanakura, E. Sato, Y. Fukumori, et al. 2013. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. Proc. Natl. Acad. Sci. USA 110: 17945-17950.
88. Pere, H., Y. Montier, J. Bayry, F. Quintin-Colonna, N. Merillon, E. Dransart, C. Badoual, A. Gey, P. Ravel, E. Marcheteau, et al. 2011. A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. Blood 118: 4853-4862.
89. Facciabene, A., X. Peng, I. S. Hagemann, K. Balint, A. Barchetti, L.-P. Wang, P. A. Gimotty, C. B. Gilks, P. Lal, L. Zhang, and G. Coukos. 2011. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature 475: 226-230.